CXCL13 is a B cell attracting chemokine and while its role in A. baumannii infection is unclear, it has previously been identified as a biomarker for sepsis and a predictor of mortality in COVID-19 patients [106–108]. This evidence concerns the gene CXCL13 and Sepsis.